Copy Link to Highlight
...
RegLinks
Faron Pharmaceuticals Oy
Faron announces two bexmarilimab abstracts accepted at ASH 2025, including an oral presentation on treatment efficacy
Nov. 4, 2025, 7 a.m.
Link to Selection